Engaged in advancing innovative solutions for large-scale market applications
OMER, Israel, May 30, 2018 – Medigus Ltd. (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and an innovator in direct visualization technology, today announced that new data from its clinical research on the MUSE™ will be highlighted in poster presentations at Digestive Disease Week (DDW), June 2-5, in Washington, DC.
“The safety, efficacy and comparison data presented at DDW highlight the value of the MUSE system, which enables an incision-less procedure for GERD patients as an alternative to invasive surgical procedures who can no longer rely on drug therapy” said Chris Rowland, Chief Executive Officer of Medigus. “We are encouraged by our results to date and remain dedicated to continue building on our clinical success.”
The MUSE system is a single-use flexible transoral stapler that merges the latest advancement in microvisual, ultrasonic and surgical stapling. The device comes equipped with an ultrasonic sight and range finder and a micro ScoutCam™ CMOS camera, which enables a single physician to perform an incisionless transoral fundoplication, the procedure intended to treat the anatomical cause of gastroesophageal reflux disease (GERD). As the device requires no incisions, patients generally report greater comfort during the procedure and experience reduced hospital stays by up to 50% over invasive fundoplication procedures.
MUSE Poster Presentations – Saturday, June 2, 2018 at 12:00PM – 2PM ET, Session Number 5230, Hall C, Washington Convention Center:
• Sa1889: TRANSORAL ANTERIOR FUNDOPLICATION (TAF) WITH MEDIGUS ULTRASOUND SURGICAL ENDOSTAPLER (MUSE) FOR THE TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE (GERD): 12-MONTHS RESULTS FROM A SINGLE-CENTER PROSPECTIVE STUDY
AUTHORS: Testoni, Pier Alberto1; Mazzoleni, Giorgia1; Distefano, Giovanni1; Testoni,Sabrina G.1; Antonelli, Mario1; Fanti, Lorella1; Passaretti, Sandro1
INSTITUTIONS: 1. San Raffaele Scientific Institute- San Raffaele “Vita-Salute” University, Milan, Italy.
• Sa1926: COMPARISON BETWEEN ESOPHYX AND MUSE SYSTEMS FOR TRANSORAL INCISIONLESSFUNDOPLICATION (TIF) FOR THE TREATMENT GASTROESOPHAGEAL REFLUX DISEASE (GERD): 6 AND 12-MONTH RESULTS FROM A SINGLE-CENTER RETROSPECTIVE STUDY
AUTHORS: Testoni, Pier Alberto1; Mazzoleni, Giorgia1; Distefano, Giovanni1; Testoni,
Sabrina G.1; Fanti, Lorella1; Antonelli, Mario1; Passaretti, Sandro1
INSTITUTIONS:1. San Raffaele Scientific Institute, “Vita-Salute” San Raffaele University, Milan, Mi, Italy.
MUSE Poster Presentation – Sunday, June 3, 2018 at 12:00PM – 2PM ET, Session Number 6030, Hall C, Washington Convention Center:
• Su1122: Updated Results from an International Multi-Center Registry Study for Endoscopic Anterior Fundoplication
AUTHORS: Lankarani A, Costamagna G, Boskoski I, Nieto J, Lehman G, Kessler, WR, Seltzer D, Neuhaus H, Beyna T, Shah S, Mehta S, Haber G, Kiesslich R, Rey, JW, Starpoli A, Abu Dayyeh B, Stavropoulos S, Caca K, Chang K,